Sandostatin LAR depot 20 MG KTS
Ended Awarded Last action
- Contract number
- SPE2DR26F18VS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,914
Award facts
- Contract value 100% obligated
- $20,914.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $20,914.06, awards AmerisourceBergen Drug Corp the supply of Sandostatin LAR Depot 20 mg kits under a firm fixed price contract with the Defense Logistics Agency (DLA). The contract is non-competitive and originated as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, with a completion date of December 3, 2025. Sandostatin LAR Depot is a long-acting pharmaceutical formulation used primarily in the treatment of acromegaly and other neuroendocrine conditions.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated significant capability in federal medical procurement through competitive federal contracting. The company serves as a critical vendor for the Defense Health Agency, U.S. Coast Guard, and military healthcare systems, supplying an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order represents routine pharmaceutical fulfillment within the broader pharmaceutical prime vendor framework that the DLA utilizes to maintain consistent supply chains for military medical requirements.
Quick answers
Who was awarded contract SPE2DR26F18VS?
SPE2DR26F18VS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F18VS worth?
The government has obligated $20,914 on SPE2DR26F18VS.
Is contract SPE2DR26F18VS an order under another contract?
Yes. SPE2DR26F18VS is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F18VS competed?
The extent of competition for SPE2DR26F18VS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award